Malignant tumors of the thyroid gland are the most common of the endocrine malignancies. Although, patients with thyroid cancer have high 5 years survival rate, thyroid cancer is the most seen cause of mortality among cancers of the endocrine organs. The incidence of thyroid cancer in hyperthyroid patients varies from 0.1 to 21% in the literature. We aimed in this study to analyze the frequency of coexisting thyroid cancer and hyperthyroidism in our experience.
Results
Total 230 patients, who were operated for hyperthyroidism without the suspicion of thyroid malignancy between January 2005 and September 2010 were included in our study. Toxic multinodular goiter, toxic adenoma and Graves’ disease were diagnosed preoperatively in 187, 16 and 27 patients respectively. Histopathological thyroid malignancy was detected in 13 patients (5.7%).
Conclusion
Thyroid cancer with variable incidence up to 21% should be remembered in differential diagnosis of hyperthyroid patients.
How to cite this article
Tastan B, Dogu A, Sevim Y. Thyroid Cancer in Patients with Hyperthyroidism. World J Endoc Surg 2015;7(2):29-32.
Thyroid cancer. Medscape Medical News (serial online) 2013 Sep;9.
Cancer statistics, 2015. CA: cancer j clinicians 2015 Jan-Feb;65(1):5-29.
Thyroid carcinoma. Journal of the National Comprehensive Cancer Network: JNCCN 2010 Nov;8(11):1228-1274.
Hyperthyroidism and thyroid cancer. Archives of pathol 1966 Jun;81(6):531-535.
Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. J clinical endocrinol metabolism 1974 Jun;38(6):976-998.
Prevalence of thyroid cancer in hyperthyroid patients treated by surgery. World j surg 1998 May;22(5):473-477.
Hyperthyroidism and concurrent thyroid malignancies. Surg 1989 Jul;106(1):6-10.
Descriptive epidemiology of thyroid cancer in Hawaii. Cancer 1988 Mar 15;61(6):1272-1281.
Concurrent hyperthyroidism and thyroid carcinoma. British J Surg 1993 Oct;80(10):1301-1302.
Thyroid cancer and Graves’ disease. J Clinical Endocrinol Metabolism 1990 Apr;70(4):826-829.
Increased aggressiveness of thyroid cancer in patients with Graves’ disease. Clin Endocrinol Metabolism 1990 Apr;70(4):830-835.
Thyroid carcinoma and concurrent hyperthyroidism: a study of ten patients. Cancer 1977 Jan;39(1):298-302.
Thyroid carcinoma in Graves’ disease. Surgery 1985 Dec;98(6):1148-1153.
TSH suppression in the management of thyroid nodules and thyroid cancer. World J Surg 1981 Jan;5(1):39-47.
The role of thyroid-stimulating antibodies of Graves’ disease in differentiated thyroid cancer. New England j med 1988 Mar 24;318(12):753-759.
